Cyproheptadine, a SET7/9 inhibitor, reduces hyperglycaemia-induced ER stress alleviating inflammation and fibrosis in renal tubular epithelial cells
| dc.contributor.author | Gaikwad, Anil Bhanudas | |
| dc.date.accessioned | 2023-12-22T10:50:32Z | |
| dc.date.available | 2023-12-22T10:50:32Z | |
| dc.date.issued | 2022-08 | |
| dc.description.abstract | Persistent hyperglycaemia increases SET7/9 expression and endoplasmic reticulum (ER) stress which causes inflammation, apoptosis, and fibrosis in renal tubular epithelial cells leading to diabetic kidney disease (DKD) | en_US |
| dc.identifier.uri | https://www.tandfonline.com/doi/abs/10.1080/13813455.2022.2105365 | |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13504 | |
| dc.language.iso | en | en_US |
| dc.publisher | Taylor & Francis | en_US |
| dc.subject | Pharmacy | en_US |
| dc.subject | Cyproheptadine | en_US |
| dc.subject | Fibrosis | en_US |
| dc.subject | Diabetic kidney disease (DKD) | en_US |
| dc.title | Cyproheptadine, a SET7/9 inhibitor, reduces hyperglycaemia-induced ER stress alleviating inflammation and fibrosis in renal tubular epithelial cells | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: